Complete genome analysis identifies recombinant events and positive selection sites of hepatitis C virus from mainland China during 2010–2019

•HCV-6 was one of the dominant genotypes in mainland China during 2010–2019.•Five recombinants of Chinese epidemic strains of HCV were identified by analyzing 102 full-length genome sequences.•Selection pressure analyses revealed five positive selective sites referring to drug resistance and immune...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virus research 2021-04, Vol.296, p.198354-198354, Article 198354
Hauptverfasser: Qi, Mengdi, Yang, Mengmei, Xu, Liangzi, Ma, Chunli, Huang, Pu, Sun, Jing, Shi, Jiandong, Hu, Yunzhang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•HCV-6 was one of the dominant genotypes in mainland China during 2010–2019.•Five recombinants of Chinese epidemic strains of HCV were identified by analyzing 102 full-length genome sequences.•Selection pressure analyses revealed five positive selective sites referring to drug resistance and immune evasion. Identification of new recombinant HCV strains and positive selection sites are crucially important for the formulation of virus intervention measures. However, little is known about the recombinant variant information and positive selection sites of circulating HCV strains in mainland China. In this study, we systematically identified recombinant variants and positive selection sites of HCV in mainland China during the 2010–2019. Phylogenetic analysis results indicated that HCV-6 was one of the dominant genotypes in mainland China during 2010–2019, whereas genotypes 7 and 8 were not detected. Recombinant analysis based on 102 full-length genome sequences of Chinese epidemic strains of HCV identified four intra-genotypic recombinants (strains WYHCV286, GB28, GZ2983, and HCV156) and one inter-genotypic recombinant (strain HH075). Specifically, two breakpoints in the 5′ UTR of two recombinants, the strains HH075 and WYHCV286, are rather unusual and has not been described before. Further, selection pressure analyses revealed five positive selective sites, which were located in the core, E2, and NS5B protein. Notably, positive selective sites in NS5B and core protein may be partially responsible for the drug resistance and immune evasion. To the best of our knowledge, this study firstly reported five specific intertypic and intratypic recombinants of Chinese epidemic strains of HCV, which highlight their significance for anti−HCV treatment and vaccine development.
ISSN:0168-1702
1872-7492
DOI:10.1016/j.virusres.2021.198354